Clinical Features and Risk Factors Analysis for Acute Myocardial Infarction Patients Received ECMO

Genglong Liu1 site in 1 country80 target enrollmentJanuary 11, 2020

ConditionsAMI - Acute Mesenteric Ischemia Extracorporeal Membrane Oxygenation Complication

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: AMI - Acute Mesenteric Ischemia
Sponsor: Genglong Liu
Enrollment: 80
Locations: 1
Primary Endpoint: Survival rate
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

ECMO has been used to save the lives of many critically ill patients with cardiorespiratory dysfunction as important rescue therapy. Though the proportion of ECMO applied to this population has been increasing year by year, clinical outcomes of AMI remain poor with high in-hospital mortality. Thus, it is necessary to characterize clinical features and investigate potentially modifiable factors contributing to outcomes of AMI patients who received ECMO treatment.

Registry

clinicaltrials.gov

Start Date

January 11, 2020

End Date

January 12, 2023

Last Updated

3 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Genglong Liu

Responsible Party

Sponsor Investigator

Principal Investigator

Genglong Liu

Clinical Professor

First Affiliated Hospital, Sun Yat-Sen University

Eligibility Criteria

Inclusion Criteria

•Clinical diagnosis of Alzheimer's Disease Age more than 18

Exclusion Criteria

•Life expectancy \<1 year Prolonged cardiac arrest before VA-ECMO therapy (\>60 min) Iatrogenic myocardial infarction secondary to a percutaneous coronary intervention VA-ECMO implanted in another center before admission